Skip to main content
. 2015 Dec 22;58(12):484–490. doi: 10.3345/kjp.2015.58.12.484

Table 2. Clinical data of the 12 children having hemangioma.

Patient No. Sex Age at first presentation (wk) Gestational age (wk) Location of hemangioma Indication of treatment Age at treatment (mo) Longest×shortest diameter (cm) Thickness (max) (cm)
1* F At birth 34+1 Multifocal (thigh, lower leg, scalp) Disfigurement 2.1 2×1.8, 3.5×2, 3.5×2.5 0.4
2* F At birth 34+1 Back Disfigurement 9.5 3×2 0.3
3 M 2 Full term Abdomen Disfigurement 4.1 7.7×5.8 0.2
4 M 1 Full term Lower lip Functional risk 1.8 1.8×0.8 0.5
5 M At birth Full term Lower lip with oral mucosa Functional risk 5.3 2.5×1.5 0.4
6 M At birth Full term Cheek Rapid growth 0.8 4×4 1.0
7 F At birth Full term Eyelid Functional risk 3.7 1.5×0.6 0.2
8 F At birth 26+2 Multifocal (forehead, trunk, extremity, buttock) Disfigurement 4.2 ≤1.5×1 (9 hemangiomas) ≤0.3
9 F 1 Full term Chin Disfigurement 3.4 3×2 0.5
10 F At birth 36+3 Wrist Local complication (ulceration) 3.8 4×2 0.3
11 F 4 33+4 Back Disfigurement 4.0 3×2 0.3
12 F 2.5 Full term Hand Functional risk 1.5 3×3 0.3

*The two patients are twins. Approximate value.